Evotec SE (ETR:EVT – Get Free Report)’s stock price rose 0.9% on Thursday . The stock traded as high as €8.10 ($8.53) and last traded at €8.00 ($8.42). Approximately 382,704 shares were traded during mid-day trading, a decline of 72% from the average daily volume of 1,360,000 shares. The stock had previously closed at €7.93 ($8.35).
Evotec Stock Up 3.2 %
The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of -8.51, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05. The company has a quick ratio of 2.97, a current ratio of 1.83 and a debt-to-equity ratio of 46.81. The business’s 50-day moving average is €8.64 and its two-hundred day moving average is €7.55.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Recommended Stories
- Five stocks we like better than Evotec
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Bloom Energy: Powering the Future With Decentralized Energy
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Differences Between Momentum Investing and Long Term Investing
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
